Fujifilm Holdings’ M&A Evolution: From Photographic Film to “Healthcare & Semiconductors” – Strainer

Fujifilm HD's Business Transformation and Implications for the Medical Industry

This news explains Fujifilm HD's M&A strategy, which boldly transformed its business portfolio from photographic film technology to healthcare and semiconductor fields. This is an excellent example of corporate strategy aiming for sustainable growth by investing in promising areas without being confined to existing business frameworks in today's rapidly changing environment. In particular, active M&A in the healthcare sector, such as chromatography resins and contract development and manufacturing organization (CDMO) services for biopharmaceuticals, suggests that the company highly values the future potential of the medical and life sciences fields.

Implications in the Context of Medical M&A and Business Succession

This strategy offers important insights for considering business succession and M&A for medical institutions. The medical industry is also facing rapid changes, including the advancement of DX, an aging population, and the emergence of new technologies. Similar to Fujifilm HD, leveraging one's own strengths and technologies (e.g., high-level expertise in specific medical departments, regional trust) while considering expansion into future growth areas (preventive medicine, regenerative medicine, telemedicine, or acquisition/partnerships in related businesses) leads to the establishment of a sustainable management foundation. Third-party succession M&A should be re-evaluated not merely as a solution for 'lack of successors' but as a strategic option aiming for business 'evolution' and 'new value creation.'

Awareness for Healthcare Executives and Successors

It is crucial for hospital directors and chairpersons, around the age of 60, to concretely consider their institution's 'next growth strategy' in parallel with future business succession. At that time, rather than solely focusing on closure or廃業 (business dissolution), they should explore the possibility of further developing the business by incorporating new technologies and management resources through M&A. As exemplified by Fujifilm HD, exploring challenges and collaborations in new fields while leveraging existing strengths will be indispensable for the future management of medical institutions. Collaborating with specialized advisors to conceptualize both 'transformation' and 'succession' of your institution as a unified plan is key to avoiding a regrettable closure and continuing contributions to regional healthcare.